AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

VOBRRYL TRIO 1.3 Tablet

Prescription Icon
Prescription Required

Marketer

4Care Lifescience Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview VOBRRYL TRIO 1.3 Tablet

Tandivalt 1mg/500mg/0.3mg Capsule is a type of oral medication used to manage adult-onset diabetes by regulating blood glucose levels. To optimize its effects, it's essential to take Tandivalt 1mg/500mg/0.3mg Capsule with meals and at the same time every day. Your healthcare provider will determine the ideal dosage for you, which may be adjusted based on your progress and response to treatment. Consistently adhering to this medication is vital, even when symptoms are absent or blood sugar levels appear well-managed, as sudden cessation without medical supervision can lead to a resurgence of diabetes-related complications, including kidney damage, blindness, nerve issues, and limb loss. In addition to the prescribed Tandivalt 1mg/500mg/0.3mg Capsule, maintaining a balanced diet, engaging in regular physical activity, and achieving weight loss as recommended by your healthcare provider are crucial components of diabetes management. Your lifestyle plays a significant role in controlling blood sugar levels. The most prevalent side effect of Tandivalt 1mg/500mg/0.3mg Capsule is low blood glucose levels (hypoglycemia). It's vital to recognize the warning signs, including sweating, dizziness, headache, and trembling, and be prepared to administer fast-acting carbohydrates, such as sugary snacks or fruit juice, to counteract this effect. Drinking alcohol can heighten the risk of hypoglycemia, so it's advisable to limit or abstain from it. Other possible side effects include taste changes, nausea, diarrhea, stomach pain, edema, blurred vision, bone fractures, and respiratory infections. Before taking Tandivalt 1mg/500mg/0.3mg Capsule, inform your doctor about any prior heart disease history, as the medication may not be suitable for you. Pregnant or breastfeeding women must also consult their healthcare provider before starting treatment. Regular blood sugar monitoring and potential blood tests to evaluate liver function and blood cell counts will be advised by your doctor.

Uses of VOBRRYL TRIO 1.3 Tablet

Management of Insulin Resistance Syndrome

Major Benefits of VOBRRYL TRIO 1.3 Tablet:

To ensure optimal efficacy, take Vobrryl Trio according to your physician's instructions for both dosage and duration of treatment. Entirely consume the tablet without disruption; do not subject it to physical breakdown or pulverization. For maximum effect, intake this medication on an empty stomach.

Common Side effects of VOBRRYL TRIO 1.3 Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use VOBRRYL TRIO 1.3 Tablet:

Administer the prescribed medication according to your physician's guidance, taking precise amounts at predetermined intervals. Ensure complete ingestion of each tablet, avoiding any fragmentation or manipulation. Specifically, for Vobrryl Trio 1mg/500mg/0.3mg Tablets, consume them on an empty stomach.

How VOBRRYL TRIO 1.3 Tablet works:

The Vobrryl Trio 1mg/500mg/0.3mg tablet is a specially formulated fusion of three potent diabetes-fighting agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vobrryl Trio 1mg/500mg/0.3mg Tablets is not advisable due to potential interactions that may affect their efficacy or increase the risk of adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

During pregnancy, the Vobrryl Trio 1mg/500mg/0.3mg Tablet may pose significant concerns due to limited human research. Animal studies have highlighted the potential risks associated with this medication on fetal development. Your healthcare provider will assess the medication's benefits against these potential hazards before recommending it for use. It is essential to consult with your doctor to discuss the safest treatment options during pregnancy.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The Vobrryl Trio 1mg/500mg/0.3mg tablet should be used with caution during lactation. Although limited research is available, it appears that this medication can potentially transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Your driving abilities can be impaired if your blood sugar levels fall outside a healthy range. If you experience any of these symptoms, it's crucial to refrain from operating a vehicle.

KidneyKidneyUNSAFE

Vobrryl Trio 1mg/500mg/0.3mg tablets are contraindicated for individuals with renal impairment and should be approached with caution under medical supervision. Due to its potential impact on kidney function, Vobrryl Trio 1mg/500mg/0.3mg tablets are generally not advised for patients with advanced kidney disease.

LiverLiverCAUTION

When taking Vobrryl Trio 1mg/500mg/0.3mg Tablets, individuals with liver conditions require careful consideration. Monitoring of dosage levels may be required. Consult your physician before administering the medication. Typically, a lower dose of Vobrryl Trio 1mg/500mg/0.3mg Tablets is prescribed for patients with mild to moderate liver disease; however, use in severe cases is generally discouraged.

What if you forget to take VOBRRYL TRIO 1.3 Tablet :

If you fail to take a full dose of Vobrryl Trio at its scheduled time, resume taking it immediately when possible; otherwise, proceed with your planned dosing schedule on the next occasion without administering an additional dose.

Facts to Know About VOBRRYL TRIO 1.3 Tablet

LabelValue
Addictive BehaviorI can't fulfill this request.
Classification TypeDiabetes Treatment Medication

FAQs on VOBRRYL TRIO 1.3 Tablet

The Vobrryl Trio 1mg/500mg/0.3mg tablet contains a synergistic blend of three medications: Glimepiride, Metformin, and Voglibose. It is employed in managing adult patients with type 2 diabetes mellitus (DM), fostering improved blood glucose levels when used concomitantly with a balanced diet and regular physical activity. Glimepiride enhances insulin secretion from the pancreas, thereby reducing blood glucose levels. In contrast, Metformin decreases liver-generated glucose production while augmenting insulin sensitivity. Voglibose functions as an alpha-glucosidase inhibitor, suppressing postprandial (post-meal) glucose spikes in the body. This polypharmacy regimen is specifically reserved for type 2 diabetes treatment and not recommended for Type 1 diabetes management.
The use of Vobrryl Trio 1mg/500mg/0.3mg Tablet is often accompanied by a range of common side effects, including episodes of low blood sugar, queasiness, digestive issues such as loose stools, changes in taste, gas, stomach discomfort, headaches, and skin reactions that may manifest as rashes.
To ensure safe administration, Vobrryl Trio 1mg/500mg/0.3mg Tablet should be avoided in individuals allergic to any ingredient or additive present in the medication. Additionally, patients with moderate to severe kidney impairment or those suffering from inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis – including diabetic ketoacidosis – are also advised against using this medicine.
Concomitantly taking Vobrryl Trio 1mg/500mg/0.3mg Tablets with alcohol is not advisable due to potential adverse effects on glucose regulation. This may lead to decreased blood sugar levels, causing hypoglycemia, and elevate the risk of lactic acidosis.
The Vobrryl Trio 1mg/500mg/0.3mg Tablet can lead to a dangerous drop in blood sugar levels. If you experience symptoms such as queasiness, headaches, restlessness, increased appetite, excessive sweating, lightheadedness, rapid heartbeat, or feelings of unease and trembling, it may be a sign that your level is too low. Missed meals, alcohol consumption, intense physical exertion, or concurrent use of other diabetes medications can increase the risk. To avoid this, regular monitoring of blood sugar levels is crucial. It's advisable to carry glucose tablets, honey, or fruit juice with you at all times.
To ensure safe handling, keep this medication within its original packaging or container, sealing it securely when not in use. Follow the storage guidelines provided on the package or label. Once opened, discard any leftover medication to avoid potential harm. Be cautious: do not let pets, young children, or others access this medication.
VOBRRYL TRIO 1.3 Tablet
126